Healthcare


 AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

December 10, 2020 11:01 AM GMT| By Kunal Sawhney

Summary The executive vice-president at AstraZeneca biopharmaceuticals R&D Sir Menelas Pangalos has expressed his doubts over early FDA approval for their vaccine AstraZeneca has been facing criticism since it paused its Phase 3 trials in S.....

 Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

December 09, 2020 09:10 AM GMT| By Team Kalkine Media

The fully integrated specialty pharmaceutical group, Allergy Therapeutics PLC has said that all the resolutions which were proposed at its Annual General Meeting (AGM) on Tuesday were passed, barring one the resolution 10. Resolution 10 talks abou.....

 Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

December 09, 2020 08:45 AM GMT| By Team Kalkine Media

Summary US FDA has commended the expeditious response of Pfizer and BioNTech in Covid-19 vaccine development Pfizer-BioNTech co-developed coronavirus vaccine exhibits safety and overwhelmingly high efficacy In a further advancement in the .....

 What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

December 07, 2020 02:41 PM GMT| By Kunal Sawhney

Summary N4 Pharma Plc has reported an increase of 5.9% in operating loss during H1 FY20. The Company has started the first phase of research to test the stability of different formulations of Nuvec® in collaboration with Nanomerics Limited......

 Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

December 04, 2020 06:03 AM GMT| By Kunal Sawhney

The United Kingdom administration is all set to get the very first doses of the clinically-approved coronavirus vaccine developed by Pfizer-BioNTech much ahead than other countries, especially the United States, where the vaccine is still under Foo.....

 Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay

Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay

December 03, 2020 09:18 AM GMT| By Hina Chowdhary

Summary In a first, the UK has swiftly approved the Pfizer-BioNTech developed coronavirus vaccine The drug regulators across various nations including the US and the EU’s basket of countries are working on expediting the approval process .....

 MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week

MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week

December 02, 2020 08:21 AM GMT| By Kunal Sawhney

In a historic development, the Medicines and Healthcare Products Regulatory Authority (MHRA) of the United Kingdom has given approval to the Pfizer-BioNTech vaccine. With this, the UK has become the first western country ahead of the US and Europe to...

 UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'

UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'

December 02, 2020 07:53 AM GMT| By Team Kalkine Media

In a major development, the United Kingdom on Wednesday became the first nation to approve the Pfizer-BioNTech vaccination for public use. The COVID-19 mRNA vaccine candidate will be rolled out from next week, informed UK health secretary Matt Hancoc...

 AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe

AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe

December 01, 2020 04:20 PM GMT| By Kunal Sawhney

AstraZeneca PLC (LON: AZN) will be selling its rights of Crestor and some related medicines to Germany-based Grünenthal GmbH in more than 30 countries of Europe except the UK and Spain. The deal is worth up to $350 million. AstraZeneca will con...

 Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday

Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday

November 28, 2020 10:50 AM GMT| By Hina Chowdhary

Shares of Indivior, the Chesterfield-headquartered pharmaceuticals company, crashed nearly 20 per cent at the close of the trading window on Friday, 28 November after the Slough-based healthcare-to-consumer goods manufacturer Reckitt Benckiser Group...

 Oxford Covid-19 vaccine faces questions after dosing error

Oxford Covid-19 vaccine faces questions after dosing error

November 27, 2020 09:11 AM GMT| By Kunal Sawhney

Though the recent back-to-back advancements in the development of a vaccine seemed to have enhanced the visibility of a silver lining in the fight against Covid-19 (SARS-CoV-2) virus, the hope of getting a clinically-approved vaccine remains bleak un...

 Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)

Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)

November 24, 2020 09:04 AM GMT| By Kunal Sawhney

The pharmaceuticals industry has also been gripped by the aftereffects of coronavirus pandemic as even the pharma shares representing some of the major corporations like Novartis AG (NYSE: NVS), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) have been...

 COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials

COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials

November 23, 2020 02:41 PM GMT| By Hina Chowdhary

Summary AstraZeneca said the Covid-19 vaccination, which the firm has been developing along with Oxford University, has shown a 70 per cent efficacy AstraZeneca CEO Pascal Soriot said the results are positive and show that it is highly effectiv.....

 Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval

Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval

November 21, 2020 12:44 PM GMT| By Kunal Sawhney

  Pfizer and its partner BioNTech have submitted their report seeking early approvals from FDA for its Covid-19 vaccine The company has also started with its submissions in other countries such as Australia, Canada, Europe, Japan and the UK...

 Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials

Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials

November 12, 2020 04:37 PM GMT| By Kunal Sawhney

Summary The vaccine candidate was found to be 90 per cent efficient in preventing Covid-19 infection, making it one of the most effective against the virus. The vaccine, however, is not going to be available for at least a few months before the.....

 Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results

Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results

November 10, 2020 09:23 AM GMT| By Hina Chowdhary

Stock markets across the world witnessed a sharp uptick on Monday after initial data of a clinical trial showed that Pfizer and BioNTech’s vaccine candidate was more than 90 per cent effective in preventing COVID-19. Shares of both the pharm.....

 GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments

GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments

November 10, 2020 04:33 AM GMT| By Hina Chowdhary

GE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. .....

 Arix Bioscience plc’s VelosBio to be acquired by Merck

Arix Bioscience plc’s VelosBio to be acquired by Merck

November 06, 2020 01:36 PM GMT| By Team Kalkine Media

Summary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew by 12 times Merck acquired VelosBio to bolster its oncology pipeline The global venture capit.....

 TFF Pharmaceuticals releases results for Q3 2020

TFF Pharmaceuticals releases results for Q3 2020

November 06, 2020 11:15 AM GMT| By Kunal Sawhney

Summary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology platform, Thin Film Freezing, or TFF helps it in developing and commercializing innovative drug prod.....

 How are these two AIM stocks performing: LiDCO Group Plc and TomCo Energy Plc?

How are these two AIM stocks performing: LiDCO Group Plc and TomCo Energy Plc?

November 03, 2020 02:27 PM GMT| By Kunal Sawhney

Summary LiDCO Group Plc witnessed sales growth of 75% year-on-year during H1 FY21. The Company is getting acquired by Masimo Corporation. TomCo Energy Plc's POSP is expected to be operational by November 2020. The estimated capital cost for a.....

Recent Articles






Investing Tips

Previous Next